Document:

Exhibit 4.1

 

LAKELAND INDUSTRIES, INC.

2012 STOCK INCENTIVE PLAN

 

Section 1.          Purpose
of the Plan. The purpose of the Lakeland Industries, Inc. 2012 Stock Incentive Plan (the “Plan”) is to assist the
Company and its Subsidiaries in attracting and retaining valued Employees and Non-Employee Directors by offering them a greater
stake in the Company’s success and a closer identity with it, and to encourage ownership of the Company’s stock by
such Employees and Non-Employee Directors.

 

Section 2.          Definitions.
As used herein, the following definitions shall apply:

 

2.1.          “Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly, is in control of, is controlled by, or is under
common control with, such Person. For purposes of this definition, “control” of a Person means the power, directly
or indirectly, to direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.

 

2.2.          “Award”
means the grant of Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units or other stock-based awards
under the Plan.

 

2.3.          “Award
Agreement” means the written agreement, instrument or document evidencing an Award.

 

2.4.          “Board”
means the Board of Directors of the Company.

 

2.5.          “Cause”
means,

 

(a)          if
the applicable Participant is party to an effective employment, severance or similar agreement with the Company or a Subsidiary,
and such term is defined therein, “Cause” shall have the meaning provided in such agreement;

 

(b)          if
the applicable Participant is not a party to an effective employment, severance or similar agreement or if no definition of “Cause”
is set forth in the applicable employment, severance or similar agreement, “Cause” shall have the meaning provided
in the applicable Award Agreement; or

 

(c)          if
neither (a) nor (b) applies, then “Cause” shall mean, as determined by the Committee in its sole discretion, (i) the
Participant’s willful misconduct or negligence in connection with the performance of the Participant’s duties for the
Company or its Subsidiaries; (ii) the Participant’s conviction of, or a plea of guilty or nolo contendere to, a felony
or a crime; (iii) the Participant’s engaging in any business that directly or indirectly competes with the Company or its
Subsidiaries; or (iv) disclosure of trade secrets, customer lists or confidential information of the Company or its Subsidiaries
to a competitor or an unauthorized Person.

 

2.6.          “Change
in Control” means, unless otherwise provided in an Award Agreement:

 

    	 

    	 

    

 

(a)          the
acquisition in one or more transactions by any “person” (as such term is used for purposes of Section 13(d) or Section
14(d) of the Exchange Act) but excluding, for this purpose, (i) the Company or its Subsidiaries, and (ii) any employee benefit
plan of the Company or its Subsidiaries, of “beneficial ownership” (within the meaning of Rule 13d-3 under the Exchange
Act) of more than fifty percent (50%) of the combined voting power of the Company’s then outstanding voting securities (the
“Voting Securities”);

 

(b)          the
consummation of a merger or consolidation involving the Company if the shareholders of the Company, immediately before such merger
or consolidation, do not own, directly or indirectly, immediately following such merger or consolidation, at least fifty percent
(50%) of the combined voting power of the outstanding voting securities of the corporation resulting from such merger or
consolidation in the same proportions as owed immediately prior to the merger or consolidation;

 

(c)          individuals
who, as of the Effective Date, constitute the Board (the “Incumbent Board”) cease for any reason to constitute
at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose
election, or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of the
directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board,
but excluding, as a member of the Incumbent Board, any such individual whose initial assumption of office occurs as a result of
either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the
Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of any “person” (as
such term is used for purposes of Section 13(d) or Section 14(d) of the Exchange Act) other than the Board; or

 

(d)          the
acquisition by any “person” (as such term is used for purposes of Section 13(d) or Section 14(d) of the Exchange Act)
in a single transaction or in a series of related transactions occurring during any period of 12 consecutive months, of assets
from the Company that have a total gross fair market value equal to or more than 51% of the total gross fair market value of all
of the assets of the Company immediately prior to such acquisition or acquisitions.

 

2.7.          
“Code” means the Internal Revenue Code of 1986, as amended.

 

2.8.          “Common
Stock” means the common stock of the Company, par value $0.01 per share.

 

2.9.          “Company”
means Lakeland Industries, Inc., a Delaware corporation, or any successor corporation.

 

2.10.         “Committee”
means the Compensation Committee of the Board, provided that the Committee shall at all times have at least two members, each of
whom shall (i) be a “non-employee director” as defined in Rule 16b-3 under the Exchange Act, (ii) be an “outside
director” as defined in Section 162(m) of the Code and the regulations issued thereunder and (iii) satisfy such other independence
requirements for members of a compensation committee as may be applicable under the rules of the securities exchange or association
on which the Common Stock is then traded or listed.

 

    	 

    	 

    

 

2.11.         “Disability”
means, unless otherwise provided in an Award Agreement, that the Participant is unable to engage in any substantial gainful activity
by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted
or can be expected to last for a continuous period of not less than 12 months.

 

2.12.         “Effective
Date” means June 20, 2012, the date that the Plan was approved by the shareholders of the Company.

 

2.13.         “Employee”
means an individual who is an officer or employee of the Company or a Subsidiary, including a director who is such an employee
and whose earnings are reported on a Form W-2.

 

2.14.         “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

2.15.         “Fair
Market Value” means, on any given date (i) if the shares of Common Stock are then listed on a national securities exchange,
including the Nasdaq Global Market (“NASDAQ”), the closing sales price per share of Common Stock on the exchange for
such date, or if no sale was made on such date on the exchange, on the last preceding day on which a sale occurred; (ii) if shares
of Common Stock are not then listed on a national securities exchange but are then quoted on another stock quotation system, the
closing price for the shares of Common Stock as quoted on such quotation system on such date, or if no sale was made on such date
on such quotation system, on the last preceding day on which a sale was made; or (iii) if (i) and (ii) do not apply, such value
as the Committee in its discretion may in good faith determine in accordance with Section 409A of the Code and the regulations
thereunder.

 

2.16.         “Non-Employee
Director” means a member of the Board who is not an Employee.

 

2.17.         
“Participant” means any Employee or Non-Employee Director who receives an Award.

 

2.18.         “Performance
Cycle” means the period of time of not fewer than two years or more than five years as specified by the Committee over
which Performance Shares or Performance Units are to be earned.

 

    	 

    	 

    

 

2.19.         
“Performance Goals” means any goals established by the Committee in its sole discretion, the attainment of which
is substantially uncertain at the time such goals are established. Performance Goals may be described in terms of Company-wide
objectives or objectives that are related to the performance of the individual Participant or a Subsidiary, division, department
or function within the Company or Subsidiary in which the Participant is employed. Performance Goals may be measured on an absolute
or relative basis. Relative performance may be measured by a group of peer companies or by a financial market index. Performance
Goals may be based upon: specified levels of or increases in the Company’s, a division’s or a Subsidiary’s return
on capital, equity or assets; earnings measures/ratios (on a gross, net, pre-tax or post-tax basis), including diluted earnings
per share, total earnings, operating earnings, earnings growth, earnings before interest and taxes (EBIT) and earnings before interest,
taxes, depreciation and amortization (EBITDA); net economic profit (which is operating earnings minus a charge to capital); net
income; operating income; sales; sales growth; gross margin; direct margin; operating profit; per period or cumulative cash flow
(including but not limited to operating cash flow and free cash flow) or cash flow return on investment (which equals net cash
flow divided by total capital); inventory turns; financial return ratios; market share; balance sheet measurements such as receivable
turnover; improvement in or attainment of expense levels; improvement in or attainment of working capital levels; debt reduction;
strategic innovation, including but not limited to entering into, substantially completing, or receiving payments under, relating
to, or deriving from a joint development agreement, licensing agreement, or similar agreement; customer or employee satisfaction;
individual objectives; any financial or other measurement deemed appropriate by the Committee as it relates to the results of operations
or other measurable progress of the Company and its Subsidiaries (or any business unit of the Company or any of its Subsidiaries);
and any combination of any of the foregoing criteria. If the Committee determines that a change in the business, operations, corporate
structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances
render the Performance Goals unsuitable, the Committee may modify such Performance Goals or the related minimum acceptable level
of achievement, in whole or in part, as the Committee deems appropriate and equitable.

 

2.20.         “Performance
Shares” or “Performance Units” means an Award made pursuant to Section 6.3 of the Plan.

 

2.21.         “Person”
means an individual, corporation, partnership, association, limited liability company, estate or other entity.

 

2.22.         “Restricted
Stock” means Common Stock awarded by the Committee under Section 6.1 of the Plan.

 

2.23.         “Restricted
Stock Unit” means the right granted under Section 6.2 of the Plan to receive, on the date of settlement, an amount equal
to the Fair Market Value of one share of Common Stock. Restricted Stock Units may be settled in cash, shares of Common Stock or
any combination of cash and shares of Common Stock; provided, however, that unless otherwise provided in an Award Agreement, Restricted
Stock Units shall be settled in shares of Common Stock.

 

2.24.         “Restriction
Period” means the period during which Restricted Stock and Restricted Stock Units are subject to forfeiture.

 

2.25.         “Securities
Act” means the Securities Act of 1933, as amended.

 

2.26.         “Subsidiary”
means any corporation, partnership, joint venture or other business entity of which 50% or more of the outstanding voting power
is beneficially owned, directly or indirectly, by the Company.

 

Section 3.          Eligibility.
Any Employee or Non-Employee Director who is selected by the Committee shall be eligible to receive an Award under the Plan.

 

    	 

    	 

    
 

Section 4.          Administration
and Implementation of the Plan.

 

4.1.          The
Plan shall be administered by the Committee; provided, however, that with respect to Non-Employee Directors (i) the Plan shall
be administered by the full Board and (ii) all references in the Plan to the Committee shall be deemed to refer to the Board. Any
action of the Committee in administering the Plan shall be final, conclusive and binding on all Persons, including the Company,
its Subsidiaries, Participants, Persons claiming rights from or through Participants and shareholders of the Company.

 

4.2.          Notwithstanding
Section 4.1, the Committee may delegate to one or more officers or Board members the authority to grant Awards to eligible individuals
who are not subject to the requirements of Rule 16b-3 of the Exchange Act or “covered employees” within the meaning
of Section 162(m) of the Code and the regulations thereunder.

 

4.3.          Subject
to the provisions of the Plan, the Committee shall have full and final authority in its discretion to (i) select the Employees
and Non-Employee Directors who will receive Awards pursuant to the Plan; (ii) determine the type or types of Awards to be granted
to each Participant; (iii) determine the number of shares of Common Stock to which an Award will relate, the terms and conditions
of any Award granted under the Plan (including, but not limited to, restrictions as to vesting, transferability or forfeiture,
exercisability or settlement of an Award and waivers or accelerations thereof, and waivers of or modifications to Performance Goals
relating to an Award, based in each case on such considerations as the Committee shall determine) and all other matters to be determined
in connection with an Award; (iv) determine the exercise price, base price or purchase price (if any) of an Award; (v) determine
whether, to what extent, and under what circumstances an Award may be cancelled, forfeited, or surrendered; (vi) determine whether,
and to certify that, Performance Goals to which an Award is subject are satisfied; (vii) correct any defect or supply any omission
or reconcile any inconsistency in the Plan, and adopt, amend and rescind such rules, regulations, guidelines, forms of agreements
and instruments relating to the Plan as it may deem necessary or advisable; (viii) construe and interpret the Plan; and (ix) make
all other determinations as it may deem necessary or advisable for the administration of the Plan; provided, however, that the
Committee shall be prohibited from effecting a repricing of any outstanding Award without shareholder approval.

 

Section 5.          Shares
of Common Stock Subject to the Plan.

 

5.1.          Subject
to adjustment as provided in Section 9 hereof, the total number of shares of Common Stock available for Awards under the Plan shall
be 310,000. Notwithstanding the foregoing, Awards covering no more than 60,000 shares of Common Stock may be awarded to any Participant
in any one calendar year. Common Stock awarded under the Plan may be reserved or made available from the Company’s authorized
and unissued Common Stock or from Common Stock reacquired (through open market transactions or otherwise) and held in the Company’s
treasury. Any shares of Common Stock issued by the Company through the assumption or substitution of outstanding grants from an
acquired company shall not reduce the shares of Common Stock available for Awards under the Plan.

 

    	 

    	 

    

 

5.2.          If
any shares subject to an Award under the Plan are forfeited or such Award otherwise terminates or is settled for any reason whatsoever
without an actual distribution of shares to the Participant, any shares counted against the number of shares available for issuance
pursuant to the Plan with respect to such Award shall, to the extent of any such forfeiture, settlement, or termination, again
be available for Awards under the Plan; provided, however, that the Committee may adopt procedures for the counting of shares relating
to any Award to ensure appropriate counting, avoid double counting, provide for adjustments in any case in which the number of
shares actually distributed differs from the number of shares previously counted in connection with such Award, and if necessary,
to comply with applicable law or regulations.

 

Section 6.          Awards.
Awards may be granted on the terms and conditions set forth in this Section 6. In addition, the Committee may impose on any Award
or the settlement or exercise thereof, at the date of grant or thereafter, such additional terms and conditions, not inconsistent
with the provisions of the Plan, as the Committee shall determine, including without limitation terms requiring forfeiture of Awards
in the event of the termination of a Participant’s employment or other relationship with the Company or any Subsidiary; provided,
however, that the Committee shall retain full power to accelerate or waive any such additional term or condition as it may have
previously imposed (provided that, in any case, any such action is permitted under Code Section 409A and, with respect to an Award
intended to satisfy the “qualified performance-based compensation” exception under Code Section 162(m), does not cause
such Award to fail to satisfy such exception). The right of a Participant to exercise or receive a grant or settlement of any Award,
and the timing thereof, may be subject to such Performance Goals as may be determined by the Committee. Each Award, and the terms
and conditions applicable thereto, shall be evidenced by an Award Agreement.

 

6.1.          Restricted
Stock. An Award of Restricted Stock is a grant by the Company of a specified number of shares of Common Stock to the Participant,
which shares are subject to forfeiture upon the happening of specified events during the Restriction Period. An Award of Restricted
Stock shall be subject to the following terms and conditions:

 

(a)          General.
Each Award Agreement with respect to Restricted Stock shall specify the duration of the Restriction Period, if any, and/or each
installment thereof, the conditions under which the Restricted Stock may be forfeited to the Company, and the amount, if any, the
Participant must pay to receive the Restricted Stock. Such restrictions may include a vesting schedule based upon the passage of
time, the attainment of Performance Goals or a combination thereof.

 

(b)          Transferability.
During the Restriction Period, if any, the transferability of Restricted Stock shall be prohibited or restricted in the manner
and to the extent prescribed in the applicable Award Agreement. Such restrictions may include, without limitation, rights of repurchase
or first refusal in the Company or provisions subjecting the Restricted Stock to a continuing substantial risk of forfeiture in
the hands of any transferee.

 

(c)          Shareholder
Rights. Unless otherwise provided in the applicable Award Agreement, during the Restriction Period the Participant shall have
all the rights of a shareholder with respect to Restricted Stock, including, without limitation, the right to receive dividends
thereon (whether in cash or shares of Common Stock) and to vote such shares of Restricted Stock. Dividends shall be subject to
the same restrictions as the underlying Restricted Stock unless otherwise provided by the Committee (and the Committee may, in
its sole discretion, withhold any cash dividends paid on Restricted Stock until the restrictions applicable to such Restricted
Stock have lapsed).

 

    	 

    	 

    

 

(d)          Termination
of Employment. Unless otherwise provided in an Award Agreement or as may be determined by the Committee:

 

(i)          Due
to Death or Disability. Upon a Participant’s termination of employment with the Company and its Subsidiaries before the end
of a Restriction Period by reason of his or her death or permanent Disability, the Restriction Period for such Participant for
the purpose of determining the amount of the Award payable, if any, shall end at the end of the calendar quarter immediately preceding
the date of which said Participant ceased to be employed by the Company or its Subsidiaries. The amount of an Award payable to
a Participant (or the beneficiary of a deceased Participant) to whom the preceding sentence is applicable shall be paid at the
end of the Restriction Period, provided all other restrictions on the Restricted Stock have been satisfied, and shall be that fraction
of the Award computed pursuant to the preceding sentence the numerator of which is the number of full calendar quarters during
the Restriction Period during all of which said Participant was an employee of the Company or its Subsidiaries and the denominator
of which is the number of full calendar quarters in the Restriction Period.

 

(ii)         Due
to Reasons Other Than Death or Disability. Upon any other termination of employment of a Participant with the Company and its Subsidiaries
for any reason, the unvested portion of each Award of Restricted Stock held by such Participant shall be forfeited with no further
compensation due the Participant.

 

6.2.          Restricted
Stock Units. Restricted Stock Units are solely a device for the measurement and determination of the amounts to be paid to
a Participant under the Plan. Restricted Stock Units do not constitute Common Stock and shall not be treated as (or as giving rise
to) property or as a trust fund of any kind. The right of any Participant in respect of an Award of Restricted Stock Units shall
be no greater than the right of any unsecured general creditor of the Company.  The grant
of Restricted Stock Units shall be subject to the following terms and conditions:

 

(a)          Restriction
Period. Each Award Agreement with respect to Restricted Stock Units shall specify the duration of the Restriction Period, if
any, and/or each installment thereof and the conditions under which such Award may be forfeited to the Company. Such restrictions
may include a vesting schedule based upon the passage of time, the attainment of Performance Goals or a combination thereof.

 

(b)          Termination
of Employment. Unless otherwise provided in an Award Agreement or as may be determined by the Committee:

 

(i)          Due
to Death or Disability. Upon a Participant’s termination of employment with the Company and its Subsidiaries before the end
of a Restriction Period by reason of his or her death or permanent Disability, the Restriction Period for such Participant for
the purpose of determining the amount of the Award payable, if any, shall end at the end of the calendar quarter immediately preceding
the date of which said Participant ceased to be employed by the Company or its Subsidiaries. The amount of an Award payable to
a Participant (or the beneficiary of a deceased Participant) to whom the preceding sentence is applicable shall be paid at the
end of the Restriction Period, provided all other restrictions on the Restricted Stock Units have been satisfied, and shall be
that fraction of the Award computed pursuant to the preceding sentence the numerator of which is the number of full calendar quarters
during the Restriction Period during all of which said Participant was an employee of the Company or its Subsidiaries and the denominator
of which is the number of full calendar quarters in the Restriction Period.

 

    	 

    	 

    

 

(ii)         Due
to Reasons Other Than Death or Disability. Upon any other termination of employment of a Participant prior to the lapse of restrictions,
participation in the Plan shall cease and the unvested portion of any outstanding Awards of Restricted Stock Units to such Participant
shall be forfeited with no compensation due the Participant.

 

(c)          Settlement.
Unless otherwise provided in an Award Agreement, subject to the Participant’s continued employment with the Company or a
Subsidiary from the date of grant through the expiration of the Restriction Period (or applicable portion thereof), the vested
portion of an Award of Restricted Stock Units shall be settled within 30 days after the expiration of the Restriction Period (or
applicable portion thereof).

 

(d)          Shareholder
Rights. Nothing contained in the Plan shall be construed to give any Participant rights as a shareholder with respect to an
Award of Restricted Stock Units (including, without limitation, any voting, dividend or derivative or other similar rights). Notwithstanding
the foregoing, the Committee may provide in an Award Agreement that amounts equal to any dividends declared during the Restriction
Period on the shares of Common Stock represented by an Award of Restricted Stock Units will be credited to the Participant’s
account and deemed to be reinvested in additional Restricted Stock Units, such additional Restricted Stock Units to be subject
to the same forfeiture restrictions as the Restricted Stock Units to which they relate.

 

6.3.          Performance
Shares and Performance Units. An Award of Performance Shares or Performance Units under the Plan shall entitle the Participant
to future cash payments or shares of Common Stock or a combination thereof based upon the level of achievement of pre-established
Performance Goals during a Performance Cycle.

 

(a)          Amount
of Award. The Committee shall establish a baseline and maximum amount of a Participant’s Award, which amount shall be
denominated in shares of Common Stock.

 

(b)          Communication
of Award. Each Award Agreement evidencing an Award of Performance Shares or Performance Units shall contain provisions regarding
(i) the target and maximum amount payable to the Participant pursuant to the Award, (ii) the Performance Goals and level of achievement
versus these goals that shall determine the amount of such payment, (iii) the Performance Cycle as to which performance shall be
measured for determining the amount of any payment, (iv) the timing of any payment earned by virtue of performance, (v) restrictions
on the alienation or transfer of the Award prior to actual payment, (vi) forfeiture provisions, and (vii) such further terms and
conditions in each case not inconsistent with the Plan, as may be determined from time to time by the Committee.

 

    	 

    	 

    

 

(c)          Performance
Criteria. The Performance Goals established by the Committee for any portion of an Award of Performance Shares or Performance
Units that are intended by the Committee to satisfy the requirements for “performance-based compensation” under Section
162(m) of the Code shall be selected by the Committee and specified at the time the Award is granted. Multiple Performance Goals
may be used and the components of multiple Performance Goals may be given the same or different weighting in determining the amount
of an Award earned, and may relate to absolute performance or relative performance measured against other groups, units, individuals
or entities.

 

(d)          Discretionary
Adjustments. Notwithstanding satisfaction of any Performance Goals, the amount paid under an Award of Performance Shares or
Performance Units on account of either financial performance or personal performance evaluations may be reduced by the Committee
on the basis of further considerations as the Committee shall determine.

 

(e)          Payment
of Awards. Following the conclusion of each Performance Cycle, the Committee shall determine the extent to which Performance
Goals have been attained, and the satisfaction of any other terms and conditions with respect to an Award relating to such Performance
Cycle. The Committee shall determine what, if any, payment is due with respect to any Award and whether such payment shall be made
in cash, Common Stock or a combination therof. Payment shall be made in a lump sum or installments, as determined by the Committee
at the time the Award is granted, commencing as promptly as practicable following the end of the applicable Performance Cycle,
subject to such terms and conditions and in such form as may be prescribed by the Committee. Payment in Common Stock may be in
Restricted Stock at the discretion of the Committee at the time the Award is granted.

 

(f)          Termination
of Employment. Unless otherwise provided in an Award Agreement or as may be determined by the Committee:

 

(i)          Due
to Death or Disability. Upon a Participant’s termination of employment with the Company and its Subsidiaries before the end
of a Performance Cycle by reason of his or her death or permanent Disability, the Performance Cycle for such Participant for the
purpose of determining the amount of the Award payable, if any, shall end at the end of the calendar quarter immediately preceding
the date of which said Participant ceased to be employed by the Company or its Subsidiaries. The amount of an Award payable to
a Participant (or the beneficiary of a deceased Participant) to whom the preceding sentence is applicable shall be paid at the
end of the Performance Cycle, provided the related Performance Goals have been satisfied, and shall be that fraction of the Award
computed pursuant to the preceding sentence the numerator of which is the number of full calendar quarters during the Performance
Cycle during all of which said Participant was an employee of the Company or its Subsidiaries and the denominator of which is the
number of full calendar quarters in the Performance Cycle.

 

    	 

    	 

    

 

(ii)         Due
to Reasons Other Than Death or Disability. Upon any other termination of employment of a Participant during a Performance Cycle,
participation in the Plan shall cease and the unvested portion of any outstanding Awards of Performance Shares or Performance Units
to such Participant shall be forfeited with no compensation due the Participant.

 

6.4.          Other
Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Participants any
type of Award (in addition to those Awards provided in Sections 6.1, 6.2 and 6.3 hereof) that is payable in, or valued in whole
or in part by reference to, shares of Common Stock, and that is deemed by the Committee to be consistent with the purposes of the
Plan.

 

Section 7.          Qualifying
Retirement and Disqualifying Activity.

 

7.1.          Qualifying
Retirement. Notwithstanding the provisions of Sections 6.1(d), 6.2(b) and 6.3(f)(ii) hereof, if a Participant’s employment
with the Company or its Subsidiaries terminates for any reason other than death, permanent Disability or the Participant’s
involuntary termination for Cause, and if immediately prior to the date of such termination of employment (i) the Participant is
55 years of age or older, and (ii) the sum of the Participant’s age and completed years of employment as an Employee of the
Company or its Subsidiaries (disregarding fractions in both cases) totals 70 years or more (a “qualifying retirement”),
the following provisions will apply:

 

(a)          All
shares of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units awarded to the Participant which have
vested as of the date of the qualifying retirement will be free of restrictions.

 

(b)          With
respect to any time-based Award of Restricted Stock or Restricted Stock Units which has not vested, effective as of the Participant’s
retirement date: (a) the Award will remain in effect with respect to fifty percent (50%) of the shares or units covered thereby,
and such Award will vest on the Participant’s retirement date and such shares or units will be free of restrictions as of
the vesting date; and (b) the Award will be terminated with respect to the remaining fifty percent (50%) of the shares or units
covered thereby.

 

(c)          With
respect to any performance-based Award of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units which
has not vested, effective as of the Participant’s retirement date: (a) the Award will remain in effect with respect to fifty
percent (50%) of the shares or units covered thereby and will vest upon the achievement of the related Performance Goals (unless
an Award expires according to its terms prior to the satisfaction of the Performance Goals, in which event the Award will terminate
and applicable shares of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units will be forfeited);
and (b) the Award will terminate as to the remaining fifty percent (50%) of the shares or units covered thereby. However, if the
Participant is the Chief Executive Officer of the Company or a member of his or her direct reporting group, and such person has
given the Company written notice at least one (1) full year prior to his or her qualifying retirement, no unvested performance-based
Award of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units will terminate upon such retirement,
and one hundred percent (100%) of the shares or units covered by such Award will remain in effect and will vest upon the achievement
of the related Performance Goals (unless an Award expires according to its terms prior to the satisfaction of the Performance Goals,
in which event the Award will terminate and applicable shares of Restricted Stock, Restricted Stock Units, Performance Shares or
Performance Units will be forfeited).

 

    	 

    	 

    

 

7.2.          Disqualifying
Activity. Notwithstanding the provisions of Section 7.1 hereof, if the Committee determines that the Participant is or has
engaged in any disqualifying activity (as defined below), then (1) to the extent that any Award held by such Participant has vested
as of the disqualification date (as defined below), the Participant will have the right to receive all shares or units which are
vested as of such date, and (2) to the extent that any Award held by such Participant has not vested as of the disqualification
date, the Award will terminate, and all related shares or units will be forfeited, as of such date. Any determination by the Committee,
which may act upon the recommendation of the Chief Executive Officer or other senior officer of the Company, that the Participant
is or has engaged in any disqualifying activity, and as to the disqualification date, will be final and conclusive.

 

(a)          For
purposes of this provision, the term “disqualifying activity” is defined in the Plan to include, among other activities:
(i) directly or indirectly being an owner, officer, employee, advisor or consultant to a company that competes with the Company
or its Subsidiaries or Affiliates to an extent deemed material by the Committee, or (ii) disclosure to third parties or misuse
of any confidential information or trade secrets of the Company, its Subsidiaries or Affiliates, or (iii) any material violation
of the Company’s Code of Business Conduct and Ethics or any other agreement between the Company and the Participant, or (iv)
failing in any material respect to perform his or her assigned responsibilities as an Employee of the Company or its Subsidiaries,
as determined by the Committee, in its sole judgment, after consulting with the Chief Executive Officer of the Company.

 

(b)          The
ownership of less than 2% of the outstanding voting securities of a publicly traded corporation which competes with the Company
or any of its Subsidiaries or Affiliates will not constitute a disqualifying activity.

 

(c)          The
term “disqualifying date” is defined in the Plan as the earliest date as of which the Participant engaged in any disqualifying
activity, as determined by the Committee.

 

Section 8.          Change
in Control. Notwithstanding any provision in the Plan to the contrary or unless otherwise provided in a Participant’s
employment agreement with the Company, upon the occurrence of a Change in Control, the Board, in its sole discretion, may take
one or more of the following actions with respect to any Awards that are outstanding immediately prior to such Change in Control:
(a) accelerate the vesting of all outstanding Awards such that all outstanding Awards are fully vested (effective immediately prior
to such Change in Control); (b) require the successor corporation (or its parent), following a Change in Control, to assume outstanding
Awards and/or to substitute such Awards with awards involving the common stock of such successor corporation (or its parent) on
terms and conditions necessary to preserve the rights of Participants with respect to such Awards; or (c) take such other actions
as the Board deems appropriate to preserve the rights of Participants with respect to their Awards. The judgment of the Board with
respect to any matter referred to in this Section shall be conclusive and binding upon each Participant without the need for any
amendment to the Plan.

 

    	 

    	 

    

 

Section 9.          Adjustments
upon Changes in Capitalization.

 

9.1.          In
the event that the Committee shall determine that any stock dividend, recapitalization, forward split or reverse split, reorganization,
merger, consolidation, spin-off, combination, repurchase or share exchange, extraordinary or unusual cash distribution or other
similar corporate transaction or event, affects the Common Stock such that an adjustment is appropriate in order to prevent dilution
or enlargement of the rights of Participants under the Plan, then the Committee shall proportionately and equitably adjust any
or all of (i) the number and kind of shares of Common Stock which may thereafter be issued in connection with Awards, (ii) the
number and kind of shares of Common Stock issuable in respect of outstanding Awards, (iii) the aggregate number and kind of shares
of Common Stock available under the Plan, (iv) the limits described in Section 5 of the Plan and (v) the grant price relating to
any Award or, if deemed appropriate, make provision for a cash payment with respect to any outstanding Award; provided, however,
in each case, that each adjustment shall be made in a manner that does not violate Code Section 409A and the regulations thereunder
to the extent applicable.

 

9.2.          In
addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards,
including any Performance Goals, in recognition of unusual or nonrecurring events (including, without limitation, events described
in Section 9.1) affecting the Company or any Subsidiary, or in response to changes in applicable laws, regulations, or accounting
principles. Notwithstanding the foregoing, all adjustments shall be made in a manner that does not violate Code Section 409A and
the regulations thereunder to the extent applicable.

 

Section 10.         Termination
and Amendment.

 

10.1.          Changes
to the Plan and Awards. The Board may amend, alter, suspend, discontinue, or terminate the Plan without the consent of the
Company’s shareholders or Participants, except that any such amendment, alteration, suspension, discontinuation, or termination
shall be subject to the approval of the Company’s shareholders if (i) such action would increase the number of shares subject
to the Plan, (ii) such action would decrease the price at which Awards may be granted, or (iii) such shareholder approval is required
by any applicable federal, state or foreign law or regulation or the rules of any stock exchange or automated quotation system
on which the Common Stock may then be listed or quoted, and the Board may otherwise, in its discretion, determine to submit such
other changes to the Plan to the Company’s shareholders for approval; provided, however, that without the consent of an affected
Participant, no amendment, alteration, suspension, discontinuation, or termination of the Plan may materially and adversely affect
the rights of such Participant under any outstanding Award unless such modification is necessary to ensure a deduction under Section
162(m) of the Code or to avoid the additional tax described in Section 409A of the Code.

 

    	 

    	 

    

 

10.2.          The
Committee may waive any conditions or rights under, or amend, alter, suspend, discontinue, or terminate, any Award theretofore
granted and any Award Agreement relating thereto; provided, however, that without the consent of an affected Participant, no such
amendment, alteration, suspension, discontinuation, or termination of any Award may materially and adversely affect the rights
of such Participant under such Award.

 

10.3.          Notwithstanding
anything in this Section to the contrary, any Performance Goal applicable to an Award shall not be deemed a fixed contractual term,
but shall remain subject to adjustment by the Committee, in its discretion at any time in view of the Committee’s assessment
of the Company’s strategy, performance of comparable companies, and other circumstances, except to the extent that any such
adjustment to a performance condition would adversely affect the status of an Award intended to satisfy the “qualified performance-based
compensation” exception under Section 162(m) of the Code and the regulations thereunder.

 

10.4.          Notwithstanding
anything in the Plan or an Award Agreement to the contrary, no Award may be repriced, replaced or regranted through cancellation
without the approval of the shareholders of the Company, provided that nothing herein shall prevent the Committee from taking any
action provided for in Section 9.

 

Section 11.         No
Right to Award or Employment. No Employee or Non-Employee Director shall have any claim to be granted any Award under the Plan,
and there is no obligation that the terms of Awards be uniform or consistent among Participants. Neither the Plan nor any action
taken hereunder shall be construed as giving any Participant any right to be retained in the employ of the Company or any Subsidiary.
For purposes of this Plan, a transfer of employment between the Company and its Subsidiaries shall not be deemed a termination
of employment; provided, however, that individuals employed by an entity that ceases to be a Subsidiary shall be deemed to have
incurred a termination of employment as of the date such entity ceases to be a Subsidiary unless such individual becomes an employee
of the Company or another Subsidiary as of the date of such cessation.

 

Section 12.         Taxes.
Each Participant must make appropriate arrangement for the payment of any taxes relating to an Award granted hereunder. The Company
or any Subsidiary is authorized to withhold from any payment relating to an Award under the Plan, including from a distribution
of Common Stock or any payroll or other payment to a Participant, amounts of withholding and other taxes due in connection with
any transaction involving an Award, and to take such other action as the Committee may deem advisable to enable the Company and
Participants to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award. This
authority shall include the ability to withhold or receive Common Stock or other property and to make cash payments in respect
thereof in satisfaction of a Participant’s tax obligations. Participants who are subject to the reporting requirements of
Section 16 of the Exchange Act may elect to direct the Company to withhold shares of Common Stock that would otherwise be received
upon the vesting, settlement or exercise of an Award to satisfy the withholding taxes applicable to such Award. Withholding of
taxes in the form of shares of Common Stock with respect to an Award shall not occur at a rate that exceeds the minimum required
statutory federal and state withholding rates.

 

    	 

    	 

    

 

Section 13.         Limits
on Transferability; Beneficiaries. No Award or other right or interest of a Participant under the Plan shall be pledged, encumbered,
or hypothecated to, or in favor of, or subject to any lien, obligation, or liability of such Participant to, any party, other than
the Company or any Subsidiary, or assigned or transferred by such Participant otherwise than by will or the laws of descent and
distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or
his or her guardian or legal representative. Notwithstanding the foregoing, the Committee may, in its discretion, provide that
Awards or other rights or interests of a Participant granted pursuant to the Plan be transferable, without consideration, to immediate
family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships
in which such family members are the only partners. The Committee may attach to such transferability feature such terms and conditions
as it deems advisable. In addition, a Participant may, in the manner established by the Committee, designate a beneficiary (which
may be a natural person or a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to
any Award upon the death of the Participant. A beneficiary, guardian, legal representative or other Person claiming any rights
under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement
applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary
or appropriate by the Committee.

 

Section 14.         Securities
Law Requirements.

 

14.1.          No
shares of Common Stock may be issued hereunder if the Company shall at any time determine that to do so would (i) violate the listing
requirements of an applicable securities exchange, or adversely affect the registration or qualification of the Company’s
Common Stock under any state or federal law, or (ii) require the consent or approval of any regulatory body or the satisfaction
of withholding tax or other withholding liabilities. In any of the events referred to in clause (i) or clause (ii) above, the issuance
of such shares shall be suspended and shall not be effective unless and until such withholding, listing, registration, qualifications
or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole discretion, notwithstanding
any termination of any Award or any portion of any Award during the period when issuance has been suspended.

 

14.2.          The
Committee may require, as a condition to the issuance of shares hereunder, representations, warranties and agreements to the effect
that such shares are being purchased or acquired by the Participant for investment only and without any present intention to sell
or otherwise distribute such shares and that the Participant will not dispose of such shares in transactions which, in the opinion
of counsel to the Company, would violate the registration provisions of the Securities Act, and the rules and regulations thereunder.

 

    	 

    	 

    

 

Section 15.         Code
Section 409A. The Plan and all Awards are intended to comply with, or be exempt from, Code Section 409A and all regulations,
guidance, compliance programs and other interpretative authority thereunder, and shall be interpreted in a manner consistent therewith.
Notwithstanding anything contained herein to the contrary, in the event any Award is subject to Code Section 409A, the Committee
may, in its sole discretion and without a Participant’s prior consent, amend the Plan and/or Awards, adopt policies and procedures,
or take any other actions as deemed appropriate by the Committee to (i) exempt the Plan and/or any Award from the application
of Code Section 409A, (ii) preserve the intended tax treatment of any such Award or (iii) comply with the requirements
of Code Section 409A. In the event that a Participant is a “specified employee” within the meaning of Code Section
409A, and a payment or benefit provided for under the Plan would be subject to additional tax under Code Section 409A if such payment
or benefit is paid within six (6) months after such Participant’s separation from service (within the meaning of Code Section
409A), then such payment or benefit shall not be paid (or commence) during the six (6) month period immediately following such
Participant’s separation from service except as provided in the immediately following sentence. In such an event, any payments
or benefits that would otherwise have been made or provided during such six (6) month period and which would have incurred such
additional tax under Code Section 409A shall instead be paid to the Participant in a lump-sum cash payment, without interest, on
the earlier of (i) the first business day of the seventh month following such Participant’s separation from service or (ii)
the tenth business day following such Participant’s death.

 

Section 16.         Termination.
Unless earlier terminated, the Plan shall terminate on the third anniversary of its approval by the Board, and no Awards under
the Plan shall thereafter be granted.

 

Section 17.         Fractional
Shares. The Company will not be required to issue any fractional shares of Common Stock pursuant to the Plan. The Committee
may provide for the elimination of fractions and settlement of such fractional shares of Common Stock in cash.

 

Section 18.         Discretion.
In exercising, or declining to exercise, any grant of authority or discretion hereunder, the Committee may consider or ignore
such factors or circumstances and may accord such weight to such factors and circumstances as the Committee alone and in its sole
judgment deems appropriate and without regard to the effect such exercise, or declining to exercise such grant of authority or
discretion, would have upon the affected Participant, any other Participant, any Employee or Non-Employee Director, the Company,
any Subsidiary, any Affiliate of the Company, any shareholder or any other Person.

 

Section 19.         Governing
Law. The validity and construction of the Plan and any Award Agreements entered into thereunder shall be construed and enforced
in accordance with the laws of the State of Delaware, but without giving effect to the conflict of laws principles thereof.

 

Section 20.         Effective
Date. The Plan shall become effective upon the Effective Date, and no Award shall become exercisable, realizable or vested
prior to the Effective Date.THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (the “Act”), OR
ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT THERETO UNDER THE ACT AND APPLICABLE LAWS OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE ACT AND APPLICABLE LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

	Certificate No. WC-___	Warrant to Purchase ___________ Shares of
	Dated: __________, 2012	Common Stock (subject to adjustment)

  

WARRANT
TO PURCHASE COMMON STOCK

of

BioDrain
Medical, Inc. 

 

This certifies that,
for value received, ______________, or registered assigns (the “Holder”) is entitled, subject to the terms set
forth below, to purchase from BioDrain Medical, Inc., a Minnesota corporation (the “Company”), up to ______________
shares of its common stock, par value $0.01 per share (the “Common Stock”), as constituted on the date hereof
(the “Warrant Issue Date”), upon surrender hereof, at the principal office of the Company referred to below,
with the Notice of Exercise form annexed hereto duly executed, and simultaneous payment therefor in lawful money of the United
States or otherwise as hereinafter provided, at the Exercise Price set forth in Section 2 below. The number and character of such
shares of Common Stock and the Exercise Price (defined below) are subject to adjustment as provided herein. The term “Warrant”
as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This
Warrant is being issued pursuant to the Securities Purchase Agreement, dated the date hereof, by and between the Company and the
Holder, and in connection with the corresponding Subscription Application of the Holder.

 

1.          Term
of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during
the term commencing on the Warrant Issue Date and ending at 5:00 p.m., Eastern Standard Time, on the five (5) year anniversary
of the Warrant Issue Date (the “Term”), and shall be void thereafter.

 

2.          Exercise
Price. The exercise price at which this Warrant may be exercised shall be $0.15 per share of Common Stock (the “Exercise
Price”), as such Exercise Price may be adjusted from time to time pursuant to Section 11 hereof.

 

    	 

    	 

    

  

3.          Exercise
of Warrant.

 

(a)        Method
of Exercise. The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time,
or from time to time, during the Term, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly completed
and executed on behalf of the Holder, at the principal office of the Company (or such other office or agency of the Company as
it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company), upon (i)
payment (A) in cash or by check acceptable to the Company, (B) by cancellation by the Holder of indebtedness or other obligations
of the Company to the Holder, or (C) by a combination of (A) and (B), of the purchase price of the shares to be purchased or (ii)
a net issue exercise as provided in Section 3(c) below.

 

(b)        Issuance
of Shares. This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its
surrender for exercise as provided above, and the person entitled to receive the shares of Common Stock issuable upon such exercise
shall be treated for all purposes as the holder of record of such shares as of the close of business on such date. As promptly
as practicable on or after such date and in any event within ten (10) days thereafter, the Company at its expense shall issue and
deliver to the person or persons entitled to receive the same a certificate or certificates for the number of shares issuable upon
such exercise. In the event that this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant
of like tenor exercisable for the remaining number of shares for which this Warrant may then be exercised.

 

(c)        Net
Issue Exercise. Notwithstanding any provisions herein to the contrary, if at any time from and after the 180th day
following the Warrant Issue Date until the end of the Term the shares of Common Stock issuable upon exercise of this Warrant are
not registered pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the fair market
value of one share of Common Stock is greater than the Exercise Price (at the date of calculation as set forth below), in lieu
of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value (as determined below) of this Warrant
(or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with the properly
endorsed Notice of Exercise and notice of such election, in which event the Company shall issue to the Holder a number of shares
of Common Stock computed using the following formula:

 

	X =	Y (A-B)	 
	A	 

 

	Where	X	=	The number of shares of Common Stock to be issued to the Holder
	 	 	 	 
	 	Y	=	the number of shares of Common Stock purchasable under this Warrant or, if only a portion of this Warrant is being exercised, the portion of this Warrant being canceled (at the date of such calculation)
	 	 	 	 
	 	A	=	the fair market value of one share of the Common Stock (at the date of such calculation)
	 	 	 	 
	 	B	=	Exercise Price (as adjusted to the date of such calculation).

 

    	2

    	 

    

 

 

For purposes of the above
calculation, fair market value of one share of Common Stock shall be determined by the Company’s Board of Directors in good
faith; provided, however, that where there exists a public market for the Common Stock at the time of such exercise, the fair market
value of one share of Common Stock shall be the average of the closing bid and asked prices of the Common Stock quoted on the OTC
Bulletin Board or the average closing price of the Common Stock on any national stock exchange in the United States or a foreign
country, including without limitation, the Nasdaq Stock Market, the NYSE Amex or the Toronto Stock Exchange, on which the Common
Stock is listed, whichever is applicable, as reported by Bloomberg L.P. for the five (5) trading days prior to the date of determination
of fair market value. If the Common Stock is listed on an exchange in the United States and in a foreign country, then the for
the purpose of determining fair market value hereunder, the prices on the exchange in the United States shall govern.

 

Net issue exercise
pursuant to this Section 3 shall not be available during the period from the Warrant Issue Date up to and including the 180th
day following the Warrant Issue Date.

 

4.          No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled (after aggregating all shares
that are being issued upon such exercise), the Company shall make a cash payment equal to the Exercise Price multiplied by such
fraction.

 

5.          Replacement
of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form
and substance to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense
shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 

6.          Rights
of Stockholders. Subject to Sections 9 and 11 of this Warrant, the Holder shall not be entitled to vote or receive dividends
or be deemed the holder of the Common Stock or any other securities of the Company that may at any time be issuable on the exercise
hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights
of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders
at any meeting thereof or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance, or otherwise)
or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been
exercised as provided herein.

    	3

    	 

    

 

7.          Transfer
of Warrant.

 

(a)        Warrant
Register. The Company will maintain a register (the “Warrant Register”) containing the names and addresses
of the Holder or Holders. Any Holder of this Warrant or any portion thereof may change its address as shown on the Warrant Register
by written notice to the Company requesting such change. Any notice or written communication required or permitted to be given
to the Holder may be delivered or given by mail to such Holder as shown on the Warrant Register and at the address shown on the
Warrant Register. Until this Warrant is transferred on the Warrant Register of the Company, the Company may treat the Holder as
shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary.

 

(b)        Warrant
Agent. The Company may, by written notice to the Holder, appoint an agent for the purpose of maintaining the Warrant Register
referred to in Section 7(a) above, issuing the Common Stock or other securities then issuable upon the exercise of this Warrant,
exchanging this Warrant, replacing this Warrant, or any or all of the foregoing (the “Warrant Agent”). Thereafter,
any such registration, issuance, exchange or replacement, as the case may be, shall be made at the office of the Warrant Agent.

 

(c)        Transferability
and Negotiability of Warrant. This Warrant may not be transferred or assigned in whole or in part without compliance with all
applicable federal and state securities laws by the transferor and the transferee (including the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, if such are requested by the Company). Subject to the provisions
of this Warrant with respect to compliance with the Securities Act of 1933, as amended (the “Act”), title to
this Warrant may be transferred by endorsement (by the Holder executing the Assignment Form annexed hereto) and delivery in the
same manner as a negotiable instrument transferable by endorsement and delivery.

 

(d)        Exchange
of Warrant Upon a Transfer. Upon surrender of this Warrant for exchange, properly endorsed on the Assignment Form and subject
to the provisions of this Warrant with respect to compliance with the Act and with the limitations on assignments and transfers
contained in this Section 7, the Company at its expense shall issue to or on the order of the Holder a new warrant or warrants
of like tenor, in the name of the Holder or as the Holder (on payment by the Holder of any applicable transfer taxes) may direct,
for the number of shares issuable upon exercise hereof.

 

(e)        Compliance
with Securities Laws.

 

(i)    The
Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant and the shares of Common Stock to be issued upon exercise
hereof are being acquired for investment purposes, and that the Holder will not offer, sell or otherwise dispose of this Warrant
or any shares of Common Stock to be issued upon exercise hereof except under circumstances that will not result in a violation
of the Act or any state securities laws.

 

(ii)   This
Warrant and all shares of Common Stock issued upon exercise hereof or conversion thereof shall be stamped or imprinted with a legend
in substantially the following form (in addition to any legend required by state securities laws):

 

    	4

    	 

    

 

 

THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY
NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT THERETO
UNDER SUCH ACT AND APPLICABLE LAWS OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND APPLICABLE LAWS OR AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

8.          Reservation
of Stock. The Company covenants that during the Term, the Company will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of Common Stock upon the exercise of this Warrant and, from time to time,
will take all steps necessary to amend its Certificate or Articles of Incorporation (the “Certificate”) to provide
sufficient reserves of Common Stock issuable upon exercise of this Warrant. The Company further covenants that all shares of Common
Stock that may be issued upon the exercise of rights represented by this Warrant and payment of the Exercise Price, all as set
forth herein will be duly and validly authorized and issued, fully paid and nonassessable and free from all taxes, liens and charges
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously therewith). The Company
agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing
stock certificates to execute and issue the necessary certificates for the shares of Common Stock upon the exercise of this Warrant.

 

9.          Notices.

 

(a)          Whenever
the Exercise Price or the shares purchasable hereunder shall be adjusted pursuant to Section 11 hereof, the Company shall issue
a certificate signed by its Chief Financial Officer setting forth, in reasonable detail, the event requiring the adjustment, the
amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and the shares purchasable
hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be mailed (by first-class mail,
postage prepaid) to the Holder of this Warrant.

 

(b)          In
case:

 

(i)     the
Company shall take a record of the holders of its Common Stock (or other stock or securities at the time receivable upon the exercise
of this Warrant) for the purpose of entitling them to receive any dividend or other distribution, or any right to subscribe for
or purchase any shares of stock of any class or any other securities, or to receive any other right, or

 

(ii)    of
any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger
of the Company with or into another corporation or entity, or any conveyance of all or substantially all of the assets of the Company
to another corporation or entity, or

 

    	5

    	 

    

 

(iii)   of
any voluntary or involuntary dissolution, liquidation or winding-up of the Company,

 

then, and in each such case, the Company
will mail or cause to be mailed to the Holder or Holders a notice specifying, as the case may be, (A) the date on which a record
is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend,
distribution or right, or (B) the date on which such reorganization, reclassification, consolidation, merger, conveyance, dissolution,
liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock
(or such stock or securities at the time receivable upon the exercise of this Warrant) shall be entitled to exchange their shares
of Common Stock (or such other stock or securities) for securities or other property deliverable upon such reorganization, reclassification,
consolidation, merger, conveyance, dissolution, liquidation or winding-up. Such notice shall be mailed at least 10 days prior to
the record date specified in (A) above or 20 days prior to the date specified in (B) above.

 

10.         Amendments
and Waivers.

 

(a)          Except
as provided in Section 10(b) below, this Warrant, or any provision hereof, may be amended, waived, discharged or terminated only
by a statement in writing signed by the party against which enforcement of the change, waiver, discharge or termination is sought.

 

(b)          Any
term or condition of this Warrant may be amended with the written consent of the Company and holders of at least 51% of the then
outstanding warrant shares underlying the warrants included within the Units issued to the Other Purchasers (as defined in the
SPA) and the Holder combined. Any amendment effected in accordance with this Section 10(b) shall be binding upon the Holder and
each future holder of this Warrant and the Company.

 

(c)          No
waivers of, or exceptions to, any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to
be, or construed as, a further or continuing waiver of any such term, condition or provision.

 

11.         Adjustments.
The Exercise Price and the shares purchasable hereunder are subject to adjustment from time to time as follows:

 

(a)          Merger,
Sale of Assets, etc. If at any time while this Warrant is outstanding and unexpired there shall be (i) a reorganization (other
than a combination, reclassification, exchange or subdivision of shares otherwise provided for herein), (ii) a merger or consolidation
of the Company with or into another corporation in which the Company is not the surviving entity, or (iii) a sale or transfer of
the Company’s properties and assets as, or substantially as, an entirety to any other corporation or other entity, then,
as a part of such reorganization, merger, consolidation, sale or transfer, lawful provision shall be made so that the holder of
this Warrant shall thereafter be entitled to receive upon exercise of this Warrant, during the period specified herein and upon
payment of the Exercise Price then in effect, the number of shares of stock or other securities or property of the successor corporation
or other entity resulting from such reorganization, merger, consolidation, merger, sale or transfer that a holder of the shares
deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization, consolidation, merger, sale
or transfer if this Warrant had been exercised immediately before such reorganization, merger, consolidation, sale or transfer,
all subject to further adjustment as provided in this Section 11. The foregoing provision of this Section 11(a) shall similarly
apply to successive reorganizations, consolidations, mergers, sales and transfers and to the stock or securities of any other corporation
or other entity that are at the time receivable upon the exercise of this Warrant. If the per-share consideration payable to the
Holder for shares in connection with any such transaction is in a form other than cash or marketable securities, then the fair
market value of such consideration shall be determined in accordance with Section 3(c). In all events, appropriate adjustment (as
determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions of this
Warrant with respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Warrant
shall be applicable after that event, as near as reasonably may be, in relation to any shares or other property deliverable after
that event upon exercise of this Warrant.

 

    	6

    	 

    

 

(b)          Reclassification,
etc. If the Company, at any time while this Warrant remains outstanding and unexpired, by reclassification of securities or
otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different
number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and
kind of securities as would have been issuable as the result of such change with respect to the securities that were subject to
the purchase rights under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefor
shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11.

 

(c)          Split,
Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall
split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities
of the same class, the Exercise Price for such securities shall be proportionately decreased in the case of a split or subdivision
or proportionately increased in the case of a combination and the number of such securities shall be proportionately increased
in the case of a split or subdivision or proportionately decreased in the case of a combination.

 

(d)          Dividends
in Stock or other Securities or Property. If while this Warrant remains outstanding and unexpired, the holders of the securities
as to which purchase rights under this Warrant exist (including without limitation securities into which such securities may be
converted) at the time shall have received, or, on or after the record date fixed for the determination of eligible stockholders,
shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property (other
than cash) of the Company by way of dividend, then and in each case, this Warrant shall represent the right to acquire, in addition
to the number of shares of the security receivable upon exercise of this Warrant, and without payment of any additional consideration
therefor, the amount of such other or additional stock or other securities or property (other than cash) of the Company that such
holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this
Warrant (or upon such conversion) on the date hereof and had thereafter, during the period from the date hereof to and including
the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period,
giving effect to all adjustments called for during such period by the provisions of this Section 11.

 

    	7

    	 

    

 

(e)          Calculations.
All calculations under this Section 11 shall be made to the nearest four decimal points.

 

(f)          No
Impairment. The Company will not, by amendment of its charter or through reorganization, consolidation, merger, dissolution,
sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action
as may be necessary or appropriate in order to protect the rights of the holder of this Warrant against impairment.

 

12.         Saturdays,
Sundays and Holidays. If the last or appointed day for the taking of any action or the expiration of any right granted herein
shall be a Saturday, Sunday or legal holiday, then (notwithstanding anything herein to the contrary) such action may be taken or
such right may be exercised on the next succeeding day that is not a Saturday, Sunday or legal holiday.

 

13.         Governing
Law. This Warrant shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements
made and to be performed entirely within such State, without regard to the conflicts of law principles of such State.

 

14.         Binding
Effect. The terms of this Warrant shall be binding upon and inure to the benefit of the Company and the Holder and their respective
successors and assigns.

 

[Signature
Page Follows]

 

    	8

    	 

    

 

IN WITNESS WHEREOF,
BioDrain Medical, Inc. has caused this Warrant to be executed by its officers thereunto duly authorized.

	 	 	 	 	 
	Dated: 	 	 	BioDrain Medical, Inc.
	 	 	 	 	 
	 	 	 	By: 	 
	 	 	 	 	
        Name:  Joshua Kornberg

        Title:    Chief Executive Officer

 

    	9

    	 

    

 

NOTICE OF EXERCISE

 

(1)         The
undersigned hereby (A) elects to purchase _______ shares of Common Stock of BioDrain
Medical, Inc., pursuant to the provisions of Section 3(a) of the attached Warrant, and tenders herewith payment of the
purchase price for such shares in full, or (B) elects to exercise this Warrant for the purchase of_______ shares of Common Stock,
pursuant to the provisions of Section 3(c) of the attached Warrant.

 

(2)         In
exercising this Warrant, the undersigned hereby confirms and acknowledges that the shares of Common Stock to be issued upon exercise
hereof are being acquired for investment purposes, and that the undersigned will not offer, sell or otherwise dispose of any such
shares of Common Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended,
or any applicable state securities laws.

 

(3)         Please
issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name
as is specified below:

 

	 	 
	 	(Name)
	 	 
	 	 
	 	(Name)

 

(4)         Please
issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersigned or in such other name as
is specified below:

 

	 	 
	 	(Name)

 

	 	 	 	 
	(Date)	 	(Signature)	 

 

    	10

    	 

    

 

ASSIGNMENT

 

FOR VALUE RECEIVED,
the undersigned registered owner of this Warrant hereby sells, assigns and transfers unto the Assignee named below all of the rights
of the undersigned under the within Warrant, with respect to the number of shares of Common Stock set forth below:

 

	Name of Assignee	 	Address	 	No. of Shares
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

and does hereby irrevocably constitute
and appoint ____________________________ Attorney to make such transfer on the books of BioDrain
Medical, Inc., maintained for the purpose, with full power of substitution in the premises.

 

The undersigned also
represents that, by assignment hereof, the Assignee acknowledges that this Warrant and the shares of stock to be issued upon exercise
hereof are being acquired for investment purposes, and that the Assignee will not offer, sell or otherwise dispose of this Warrant
or any shares of stock to be issued upon exercise hereof except under circumstances which will not result in a violation of the
Securities Act of 1933, as amended, or any applicable state securities laws.

 

	Dated:	 	 

 

	 	 
	 	Signature of Holder

 

    	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]